- Release Date: 17/03/22 09:58
- Summary: EMD-RX5 program advancing Phase 1 clinical trials underway
- Price Sensitive: Yes
- Download Document 255.24KB
- Forums
- ASX - By Stock
- EMD
- Ann: EMD-RX5 program advancing Phase 1 clinical trials underway
EMD
emyria limited
Add to My Watchlist
8.82%
!
3.7¢

Ann: EMD-RX5 program advancing Phase 1 clinical trials underway
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.7¢ |
Change
0.003(8.82%) |
Mkt cap ! $21.40M |
Open | High | Low | Value | Volume |
3.4¢ | 3.7¢ | 3.4¢ | $207.7K | 5.907M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 260004 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 183052 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1318713 | 0.035 |
2 | 310000 | 0.034 |
2 | 281960 | 0.033 |
3 | 430311 | 0.032 |
3 | 283508 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 1716 | 1 |
0.037 | 363052 | 3 |
0.038 | 60306 | 2 |
0.039 | 115533 | 4 |
0.040 | 494999 | 4 |
Last trade - 13.30pm 23/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |